GZ17-6.02 with proteasome inhibitors kills multiple myeloma cells
A new research paper titled "GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells" has been published in Oncotarget.
Mar 6, 2024
0
23
Cardiovascular Diseases: News and Research on Hemostatic Disorders
MeSH tree: C14.907.454
Patients see first savings from Biden's drug price push, as pharma lines up its lawyers
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with in 2010.
Feb 19, 2024
0
19
New immunotherapy for multiple myeloma proves to be more effective in the lab than CAR-T treatment already in use
Immunotherapy is already improving treatment options for many cancer types, but research groups keep exploring ways to boost the body's immune response against the tumor.
Feb 14, 2024
0
56
A patch a day? Why the vitamin skin patches hyped on social media might not be for you
Vitamin patches are trending on social media and advertised in posts and podcasts.
Feb 14, 2024
0
39
First individualized predictive model for multiple myeloma treatment
Multiple myeloma remains challenging to treat. New therapeutic advances have improved outcomes, but selecting the right treatment for a patient can be complex because the disease can vary drastically from person to person. ...
Feb 9, 2024
0
54
Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma
A new research perspective titled "Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma" has been published in Oncotarget.
Feb 7, 2024
0
40
Researchers discover that blocking ephrin B2 signaling can stop multiple myeloma growth
Cedars-Sinai Cancer investigators have discovered a protein expressed on multiple myeloma cancer cells that drives disease growth and development. The new study found that blocking part of the protein's unique signaling pathway ...
Feb 7, 2024
0
336
FDA warns of rare secondary cancer risk with CAR-T therapies
The U.S. Food and Drug Administration has told drugmakers to add a boxed warning to a type of cancer treatment called CAR-T therapy, saying the treatment itself may sometimes cause a secondary cancer.
Jan 24, 2024
0
33
Dana Farber Cancer Center to retract or fix dozens of studies
The Dana Farber Cancer Institute in Boston will retract six studies and correct 31 more as part of an ongoing investigation into claims of data manipulation.
Jan 23, 2024
1
50
Bone marrow adipocytes provide early sign of progression from MGUS to multiple myeloma
A new research perspective titled "Bone marrow adipocytes provide early sign for progression from mgus to multiple myeloma" has been published in Oncotarget.
Jan 22, 2024
0
36
